A Six-microRNA Signature Nomogram for Preoperative Prediction of Tumor Deposits in Colorectal Cancer

References

• Sung H, Ferlay J, Siegel RL, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209–249. doi:10.3322/caac.21660
   PubMed Web of Science ®Google Scholar
• Chen VW, Hsieh MC, Charlton ME, et al. Analysis of stage and clinical/prognostic factors for colon and rectal cancer from SEER registries: AJCC and collaborative stage data collection system. Cancer. 2014;120 Suppl 23:3793–3806. doi:10.1002/cncr.29056
   PubMed Web of Science ®Google Scholar
• Weiser MR. AJCC 8th Edition: colorectal Cancer. Ann Surg Oncol. 2018;25(6):1454–1455. doi:10.1245/s10434-018-6462-1
   PubMed Web of Science ®Google Scholar
• Jin M, Roth R, Rock JB, et al. The impact of tumor deposits on colonic adenocarcinoma AJCC TNM staging and outcome. Am J Surg Pathol. 2015;39(1):109–115. doi:10.1097/pas.0000000000000320
   PubMed Web of Science ®Google Scholar
• Ersen A, Unlu MS, Akman T, et al. Tumor deposits in gastric carcinomas. Pathol Res Pract. 2014;210(9):565–570. doi:10.1016/j.prp.2014.03.006
   PubMed Web of Science ®Google Scholar
• Puppa G, Ueno H, Kayahara M, et al. Tumor deposits are encountered in advanced colorectal cancer and other adenocarcinomas: an expanded classification with implications for colorectal cancer staging system including a unifying concept of in-transit metastases. Mod Pathol. 2009;22(3):410–415. doi:10.1038/modpathol.2008.198
   PubMed Web of Science ®Google Scholar
• Landau MA, Zhu B, Akwuole FN, et al. Histopathological predictors of recurrence in Stage III colon cancer: reappraisal of tumor deposits and tumor budding using AJCC8 criteria. Int J Surg Pathol. 2019;27(2):147–158. doi:10.1177/1066896918787275
   PubMed Web of Science ®Google Scholar
• Nagtegaal ID, Knijn N, Hugen N, et al. Tumor deposits in colorectal cancer: improving the value of modern staging-a systematic review and meta-analysis. J Clin Oncol. 2017;35(10):1119–1127. doi:10.1200/jco.2016.68.9091
   PubMed Web of Science ®Google Scholar
• Pei JP, Zhang CD, Liang Y, et al. A modified pathological N stage including status of tumor deposits in colorectal cancer with nodal metastasis. Front Oncol. 2020;10:548692. doi:10.3389/fonc.2020.548692
   PubMed Web of Science ®Google Scholar
• Zheng P, Chen Q, Li J, et al. Prognostic significance of tumor deposits in patients with Stage III colon cancer: a nomogram study. J Surg Res. 2020;245:475–482. doi:10.1016/j.jss.2019.07.099
   PubMed Web of Science ®Google Scholar
• Peparini N. Beyond T, N and M: the impact of tumor deposits on the staging and treatment of colorectal and gastric carcinoma. Surg Oncol. 2018;27(2):129–137. doi:10.1016/j.suronc.2018.02.007
   PubMed Web of Science ®Google Scholar
• Jin M, Frankel WL. Lymph node metastasis in colorectal cancer. Surg Oncol Clin N Am. 2018;27(2):401–412. doi:10.1016/j.soc.2017.11.011
   PubMed Web of Science ®Google Scholar
• Romano G, Veneziano D, Acunzo M, et al. Small non-coding RNA and cancer. Carcinogenesis. 2017;38(5):485–491. doi:10.1093/carcin/bgx026
   PubMed Web of Science ®Google Scholar
• Iorio MV, Croce CM. microRNA involvement in human cancer. Carcinogenesis. 2012;33(6):1126–1133. doi:10.1093/carcin/bgs140
   PubMed Web of Science ®Google Scholar
• Dawood S. Novel biomarkers of metastatic cancer. Expert Rev Mol Diagn. 2010;10(5):581–590. doi:10.1586/erm.10.35
   PubMed Web of Science ®Google Scholar
• Lv Y, Huang Z, Lin Y, et al. MiRNA expression patterns are associated with tumor mutational burden in lung adenocarcinoma. Oncoimmunology. 2019;8(10):e1629260. doi:10.1080/2162402x.2019.1629260
   PubMed Web of Science ®Google Scholar
• Nishiwada S, Sho M, Banwait JK, et al. A MicroRNA signature identifies pancreatic ductal adenocarcinoma patients at risk for lymph node metastases. Gastroenterology. 2020;159(2):562–574. doi:10.1053/j.gastro.2020.04.057
   PubMed Web of Science ®Google Scholar
• Qu A, Yang Y, Zhang X, et al. Development of a preoperative prediction nomogram for lymph node metastasis in colorectal cancer based on a novel serum miRNA signature and CT scans. EBioMedicine. 2018;37:125–133. doi:10.1016/j.ebiom.2018.09.052
   PubMed Web of Science ®Google Scholar
• Wang M, Li R, Zou X, et al. A miRNA-clinicopathological nomogram for the prediction of central lymph node metastasis in papillary thyroid carcinoma-analysis from TCGA database. Medicine (Baltimore). 2020;99(35):e21996. doi:10.1097/md.0000000000021996
   PubMed Web of Science ®Google Scholar
• Wingo PA, Jamison PM, Hiatt RA, et al. Building the infrastructure for nationwide cancer surveillance and control–a comparison between the National Program of Cancer Registries (NPCR) and the Surveillance, Epidemiology, and End Results (SEER) Program (United States). Cancer Causes Control. 2003;14(2):175–193. doi:10.1023/a:1023002322935
   PubMed Web of Science ®Google Scholar
• Zhou ZR, Wang WW, Li Y, et al. In-depth mining of clinical data: the construction of clinical prediction model with R. Ann Transl Med. 2019;7(23):796. doi:10.21037/atm.2019.08.63
   PubMed Web of Science ®Google Scholar
• Sobin LH, Fleming ID. TNM Classification of Malignant Tumors, fifth edition (1997). Union Internationale Contre le Cancer and the American Joint Committee on Cancer. Cancer. 1997;80(9):1803–1804. doi:10.1002/(sici)1097-0142(19971101)80:9<1803::aid-cncr16>3.0.co;2-9
   PubMed Web of Science ®Google Scholar
• Tong LL, Gao P, Wang ZN, et al. Is the seventh edition of the UICC/AJCC TNM staging system reasonable for patients with tumor deposits in colorectal cancer? Ann Surg. 2012;255(2):208–213. doi:10.1097/SLA.0b013e31821ad8a2
   PubMed Web of Science ®Google Scholar
• Chavali LB, Llanos AAM, Yun JP, et al. Radiotherapy for patients with resected tumor deposit-positive colorectal cancer: a surveillance, epidemiology, and end results-based population study. Arch Pathol Lab Med. 2018;142(6):721–729. doi:10.5858/arpa.2017-0099-OA
   PubMed Web of Science ®Google Scholar
• Delattre JF, Cohen R, Henriques J, et al. Prognostic value of tumor deposits for disease-free survival in patients with Stage III colon cancer: a post hoc analysis of the IDEA France Phase III trial (PRODIGE-GERCOR). J Clin Oncol. 2020;38(15):1702–1710. doi:10.1200/jco.19.01960
   PubMed Web of Science ®Google Scholar
• Li ZH, Xie PY, Zhang DF, et al. Nomogram for predicting disease-free survival among a multicenter cohort of Chinese patients with locally advanced rectal cancer. Cancer Manag Res. 2019;11:2471–2483. doi:10.2147/cmar.S196614
   PubMed Web of Science ®Google Scholar
• Wang Y, Zhang J, Zhou M, et al. Poor prognostic and staging value of tumor deposit in locally advanced rectal cancer with neoadjuvant chemoradiotherapy. Cancer Med. 2019;8(4):1508–1520. doi:10.1002/cam4.2034
   PubMed Web of Science ®Google Scholar
• Nagtegaal ID, Quirke P. Colorectal tumour deposits in the mesorectum and pericolon; a critical review. Histopathology. 2007;51(2):141–149. doi:10.1111/j.1365-2559.2007.02720.x
   PubMed Web of Science ®Google Scholar
• Song YX, Gao P, Wang ZN, et al. Can the tumor deposits be counted as metastatic lymph nodes in the UICC TNM staging system for colorectal cancer? PLoS One. 2012;7(3):e34087. doi:10.1371/journal.pone.0034087
   PubMed Web of Science ®Google Scholar
• Yagi R, Shimada Y, Kameyama H, et al. Clinical significance of extramural tumor deposits in the lateral pelvic lymph node area in low rectal cancer: a retrospective study at two institutions. Ann Surg Oncol. 2016;23(Suppl 4):552–558. doi:10.1245/s10434-016-5379-9
   PubMed Web of Science ®Google Scholar
• Atre ID, Eurboonyanun K, Noda Y, et al. Utility of texture analysis on T2-weighted MR for differentiating tumor deposits from mesorectal nodes in rectal cancer patients, in a retrospective cohort. Abdom Radiol (NY). 2021;46(2):459–468. doi:10.1007/s00261-020-02653-w
   PubMed Web of Science ®Google Scholar
• Fassan M, Vianello L, Sacchi D, et al. Assessment of intratumor immune-microenvironment in colorectal cancers with extranodal extension of nodal metastases. Cancer Cell Int. 2018;18:131. doi:10.1186/s12935-018-0634-8
   PubMed Web of Science ®Google Scholar
• Kim H, Shin S, Kim Y, et al. The clinicopathologic significance of extranodal tumor extension in locally advanced (pT3) colorectal adenocarcinoma and its association with the loss of E-cadherin expression. Int J Clin Exp Pathol. 2019;12(9):3417–3425.
   PubMed Web of Science ®Google Scholar
• Zhang M, Hu W, Hu K, et al. Association of KRAS mutation with tumor deposit status and overall survival of colorectal cancer. Cancer Causes Control. 2020;31(7):683–689. doi:10.1007/s10552-020-01313-0
   PubMed Web of Science ®Google Scholar
• Al Sahaf O, Myers E, Jawad M, et al. The prognostic significance of extramural deposits and extracapsular lymph node invasion in colon cancer. Dis Colon Rectum. 2011;54(8):982–988. doi:10.1097/DCR.0b013e31821c4944
   PubMed Web of Science ®Google Scholar
• Yamano T, Semba S, Noda M, et al. Prognostic significance of classified extramural tumor deposits and extracapsular lymph node invasion in T3-4 colorectal cancer: a retrospective single-center study. BMC Cancer. 2015;15:859. doi:10.1186/s12885-015-1885-6
   PubMed Web of Science ®Google Scholar
• Shimada Y, Takii Y. Clinical impact of mesorectal extranodal cancer tissue in rectal cancer: detailed pathological assessment using whole-mount sections. Dis Colon Rectum. 2010;53(5):771–778. doi:10.1007/DCR.0b013e3181cf7fd8
   PubMed Web of Science ®Google Scholar
• Wang S, Guan X, Ma M, et al. Reconsidering the prognostic significance of tumour deposit count in the TNM staging system for colorectal cancer. Sci Rep. 2020;10(1):89. doi:10.1038/s41598-019-57041-2
   PubMed Web of Science ®Google Scholar
• Quirke P, Williams GT, Ectors N, et al. The future of the TNM staging system in colorectal cancer: time for a debate? Lancet Oncol. 2007;8(7):651–657. doi:10.1016/s1470-2045(07)70205-x
   PubMed Web of Science ®Google Scholar
• Greene FL. Tumor deposits in colorectal cancer: a moving target. Ann Surg. 2012;255(2):214–215. doi:10.1097/SLA.0b013e3182430eaa
   PubMed Web of Science ®Google Scholar
• Zhang J, Gao D, Zhang H. Upregulation of miR-614 promotes proliferation and inhibits apoptosis in ovarian cancer by suppressing PPP2R2A expression. Mol Med Rep. 2018;17(5):6285–6292. doi:10.3892/mmr.2018.8714
   PubMed Web of Science ®Google Scholar
• Sun B, Hua J, Cui H, et al. MicroRNA-1197 downregulation inhibits proliferation and migration in human non- small cell lung cancer cells by upregulating HOXC11. Biomed Pharmacother. 2019;117:109041. doi:10.1016/j.biopha.2019.109041
   PubMed Web of Science ®Google Scholar
• Yang S, Yu F, Lin M, et al. Single-nucleotide polymorphism rs17548629 in RIPK1 gene may be associated with lung cancer in a young and middle-aged Han Chinese population. Cancer Cell Int. 2020;20:143. doi:10.1186/s12935-020-01215-w
   PubMed Web of Science ®Google Scholar
• You L, Wang J, Zhang F, et al. Potential four‑miRNA signature associated with T stage and prognosis of patients with pancreatic ductal adenocarcinoma identified by co‑expression analysis. Mol Med Rep. 2019;19(1):441–451. doi:10.3892/mmr.2018.9663
   PubMed Web of Science ®Google Scholar
• Tian L, Cao J, Ji Q, et al. The downregulation of miR-3173 in B-cell acute lymphoblastic leukaemia promotes cell invasion via PTK2. Biochem Biophys Res Commun. 2017;494(3–4):569–574. doi:10.1016/j.bbrc.2017.10.013
   PubMed Web of Science ®Google Scholar
• Yin S, Yang M, Li X, et al. Peripheral blood circulating microRNA-4636/-143 for the prognosis of cervical cancer. J Cell Biochem. 2020;121(1):596–608. doi:10.1002/jcb.29305
   PubMed Web of Science ®Google Scholar
• Tang J, Hu Y, Zhang C, et al. miR-4636 inhibits tumor cell proliferation, migration and invasion, and serves as a candidate clinical biomarker for gastric cancer. Oncol Lett. 2021;21(1):33. doi:10.3892/ol.2020.12294
   PubMed Web of Science ®Google Scholar
• Yang X, Lou J, Shan W, et al. Pathogenic roles of altered calcium channels and transporters in colon tumorogenesis. Life Sci. 2019;239:116909. doi:10.1016/j.lfs.2019.116909
   PubMed Web of Science ®Google Scholar
• Lee JM, Davis FM, Roberts-Thomson SJ, et al. Ion channels and transporters in cancer. 4. Remodeling of Ca(2+) signaling in tumorigenesis: role of Ca(2+) transport. Am J Physiol Cell Physiol. 2011;301(5):C969–76. doi:10.1152/ajpcell.00136.2011
   PubMed Web of Science ®Google Scholar
• Wang W, Yu S, Huang S, et al. A complex role for calcium signaling in colorectal cancer development and progression. Mol Cancer Res. 2019;17(11):2145–2153. doi:10.1158/1541-7786.Mcr-19-0429
   PubMed Web of Science ®Google Scholar